Daiichi Sankyo Acquires Plexxikon for $935,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d3a1345-38bc-4304-af0f-3b7fce475788&Preview=1 - Date
2/28/2011 - Company Name
Plexxikon - Mailing Address
91 Bolivar Drive Berkeley, CA 94710 - Company Description
Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including metabolic disease, oncology, inflammation, CNS and cardiovascular disease. - Website
http://www.plexxikon.com - Transaction Type
M&A - Transaction Amount
$935,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The purchase price for Plexxikon is $805 million up-front. Near-term milestone payments associated with the approval of PLX4032 could total an additional $130 million.
